Robert Gut
Direttore/Membro del Consiglio presso UNIQURE N.V.
Patrimonio netto: 171 834 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Robert Gut
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
25
| Public Company | Biotechnology | 25 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA.
8
| Extinct | Pharmaceuticals: Major | 8 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Robert Gut tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| University of Virginia | College/University | Undergraduate Degree Doctorate Degree | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Private Equity Investor | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ARAVIVE, INC. | Biotechnology | Chief Administrative Officer Director of Finance/CFO | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Tufts University | College/University | Graduate Degree | |
| JFYNetworks, Inc | Director/Board Member | ||
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
Brentwood Press & Publishing Co.
 Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Brentwood Press & Publishing Co. publishes newspapers. It offers print and digital media, website design, social media training and consultation. The company was founded by James Chamoures and is headquartered in Brentwood, CA. | Publishing: Newspapers | Chief Operating Officer | |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Information Technology Services | Corporate Officer/Principal | |
ADRx, Inc.
 ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| STEVANATO GROUP S.P.A. | Medical Specialties | Director/Board Member | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| DIANTHUS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member | |
Dianthus Therapeutics, Inc. (Massachusetts)
 Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Consultant / Advisor | |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Chairman | |
| CATALENT, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Kyowa Kirin, Inc. | Director/Board Member | ||
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Compliance Officer | |
| Georgetown University Law Center | College/University | Graduate Degree | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Corporate Officer/Principal | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| BELLICUM PHARMACEUTICALS, INC. | Biotechnology | General Counsel | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
Fortuna Fix, Inc.
 Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Biotechnology | Director/Board Member | |
| Puerto Rico USA Citizenship Foundation | Corporate Officer/Principal | ||
Ipsen Manufacturing Ireland Ltd.
 Ipsen Manufacturing Ireland Ltd. BiotechnologyHealth Technology Ipsen Manufacturing Ireland Ltd. operates as a biopharmaceutical group dedicated to improving lives through innovative medicines. The company was founded in 1989 and is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
| Stephen M. Ross School of Business | College/University | Undergraduate Degree | |
Smith & Nephew Orthopaedics Ltd.
 Smith & Nephew Orthopaedics Ltd. Medical SpecialtiesHealth Technology Part of Smith & Nephew plc, Smith & Nephew Orthopaedics Ltd. is a British company that researches, develops, and markets orthopedic devices. The company is based in Watford, UK. The company was founded in 1996. Smith & Nephew Orthopaedics was acquired by Smith & Nephew plc on March 16, 2004. | Medical Specialties | Corporate Officer/Principal | |
| SMITH & NEPHEW PLC | Medical Specialties | Corporate Officer/Principal | |
Collins Stewart, Inc.
 Collins Stewart, Inc. Investment Banks/BrokersFinance Part of Canaccord Genuity Group, Inc., Collins Stewart, Inc. is a brokerage and financial services provider. The company is based in New York, NY. The company was founded by Julian John Robins. | Investment Banks/Brokers | Corporate Officer/Principal | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. | Medical Specialties | General Counsel |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Irlanda | 3 |
| Regno Unito | 3 |
| Cina | 2 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 34 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 4 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 104 |
| Corporate Officer/Principal | 90 |
| Independent Dir/Board Member | 33 |
| Chief Tech/Sci/R&D Officer | 30 |
| Undergraduate Degree | 29 |
Contatti più connessi
| Insiders | |
|---|---|
| Kenneth Lee | 40 |
| Leonard Post | 25 |
| David Meek | 19 |
| Sander J. van Deventer | 17 |
| Jacques Suzanne | 15 |
| David Schaffer | 15 |
| Madhavan Balachandran | 15 |
| Jeremy Springhorn | 14 |
| Paula Soteropoulos | 13 |
| Steven Zelenkofske | 13 |
| Philip Astley-Sparke | 11 |
| Joshua Brumm | 11 |
| Shane Ward | 10 |
| Colin Hislop | 9 |
| Jack Kaye | 9 |
- Borsa valori
- Insiders
- Robert Gut
- Connessioni Società
